Real-time enrollment status for this recurrent non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:44 AM UTC
| NCT Number | NCT02178163 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Non-small Cell Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 1,020 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Barbara Ann Karmanos Cancer Institute |
| Last Updated on CT.gov | July 25, 2025 (Jul 25, 2025) |
As of July 13, 2026: Clinical trial NCT02178163 is currently recruiting participants. This clinical trial study for recurrent non-small cell lung cancer is actively seeking new participants at 11 locations across the United States. The study is sponsored by Barbara Ann Karmanos Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02178163 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02178163 was last updated Jul 25, 2025 (July 25, 2025). HelloStudys verifies this status automatically.